Bedston, S., Kerr, S., Bradley, D. T., Joy, M., Lowthian, E., Mulholland, R. M., . . . Sheikh, A. (2023). Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. International Journal of Epidemiology, 52(1), pp. 22-31. doi:10.1093/ije/dyac199

Bedston, Stuart, et al. "Waning of First- and Second-dose ChAdOx1 and BNT162b2 COVID-19 Vaccinations: A Pooled Target Trial Study of 12.9 Million Individuals in England, Northern Ireland, Scotland and Wales." International Journal of Epidemiology 52, no. 1 (2023): 22-31.

Bedston, Stuart, et al. "Waning of First- and Second-dose ChAdOx1 and BNT162b2 COVID-19 Vaccinations: A Pooled Target Trial Study of 12.9 Million Individuals in England, Northern Ireland, Scotland and Wales." International Journal of Epidemiology 52.1 (2023): 22-31.